...
首页> 外文期刊>Acta oncologica. >Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
【24h】

Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial

机译:皮疹,治疗结果和头部癌症患者的皮疹,治疗结果和单核苷酸多态性之间的关联患者接受EGFR抑制剂Zalutumumab:Dahanca 19试验结果

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To study the associations between development of moderate to severe skin rash, clinical outcome, and single nucleotide polymorphisms (SNPs) in candidate genes in head and neck cancer patients from the DAHANCA 19 trial receiving the EGFR-inhibitor zalutumumab concurrently with radiation treatment.
机译:目的:研究中度至重度皮疹,临床结果和单核苷酸多态性(SNP)的候选基因的开发与颈部癌患者的候选基因之间的关联与放射治疗同时接受EGFR抑制剂Zalutumumab。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号